Quantitative systems pharmacology models mechanistically describe a biological system and the effect of drug treatment on system behavior. Because these models rarely are identifiable from the available data, the uncertainty in physiological parameters may be sampled to create alternative parameterizations of the model, sometimes termed 'Virtual Patients.' In order to reproduce the statistics of a clinical population, Virtual Patients are often weighted to form a Virtual Population that reflects the baseline characteristics of the clinical cohort. Here we introduce a novel technique to efficiently generate Virtual Patients and, from this ensemble, demonstrate how to select a Virtual Population that matches the observed data without the need for weighting. This approach improves confidence in model predictions by mitigating the risk that spurious Virtual Patients become over-represented in Virtual Populations. !
! Abstract!
! Quantitative systems pharmacology models mechanistically describe a biological system and the effect of drug treatment on system behavior. Because these models rarely are identifiable from the available data, the uncertainty in physiological parameters may be sampled to create alternative parameterizations of the model, sometimes termed 'Virtual Patients.' In order to reproduce the statistics of a clinical population, Virtual Patients are often weighted to form a Virtual Population that reflects the baseline characteristics of the clinical cohort.
Here we introduce a novel technique to efficiently generate Virtual Patients and, from this ensemble, demonstrate how to select a Virtual Population that matches the observed data without the need for weighting. This approach improves confidence in model predictions by mitigating the risk that spurious Virtual Patients become over-represented in Virtual Populations. ! Introduction! ! Quantitative systems pharmacology (QSP) models are an effective approach for gaining mechanistic insight into the complex dynamics of biological systems in response to drug treatment. 1-3 QSP models in the drug discovery and development process have been utilized for increased confidence in rationale for early development targets, preclinical to clinical translation, and predictions of clinical response to novel therapeutics. To be fit for purpose, these models must include sufficient biological scope and mechanistic detail to link pathway ! 3! modulation to overall system response [4] [5] [6] [7] [8] . Due to the complexity of the biology, the iterative model-building process frequently results in a model that is a large, nonlinear, multi-scale system of equations. Many different data sources are required to quantify QSP models, including in vitro and in vivo preclinical and clinical data; moreover, the resulting models are frequently under-constrained by any one data set 9 . Therefore, to explore the impact of known variability and uncertainty [10] [11] [12] [13] [14] , QSP models are simulated using ensembles of parameterizations often termed "Virtual Patients" or "VPs." A Virtual Population that reflects individual subject and population level characteristics of a typical clinical cohort provides increased confidence that prospective simulations of response to novel therapeutics will reflect the inter-subject variability seen in the clinic, and may help to identify responders and non-responders to treatment.
Ensembles of VPs are often sufficient for exploring the broad range of responses that are possible from perturbing a model (pharmacologically or otherwise), but the outcome will not necessarily reflect the distribution (e.g., log-normal) of population level data 15 . The result is a range of predictions from the model, which are all possible outcomes but fail to provide insight into the probability of observing that outcome in a clinical trial. Previous authors have overcome this critique by weighting model outputs 13 , or model components 14 13 . This approach is intuitive and easily implemented, but this also can be computationally expensive, requires re-fitting the VPop each time VPs are added or removed from the analysis, and can result in a dramatic over-weighting of a few select VPs, which may skew the final simulation results. Schmidt et. al.
(2013) refined this approach by taking the weights off of the individual VPs and placing them on 'mechanistic axes.' 14 Their approach is computationally faster, allows new VPs to be incorporated into the VPop without refitting, and should avoid the problem of overweighting small numbers of VPs. However, their approach is not intuitive to understand or communicate and requires collecting parameters into mechanistic axes that may not explore all the variability and degeneracy in the model appropriately.
Here we propose a new algorithm for generating biologically reasonable VPops.
We will show how this algorithm compliments previous approaches by being intuitive, computationally efficient, and avoiding the problem of overweighting VPs. We demonstrate the utility of this new algorithm by fitting the joint distribution of low-density and high-density lipoproteins (LDL and HDL, respectively) from the National Health and Nutrition Examination Survey (NHANES) 16 to a previously published model of lipoprotein metabolism 17 .
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A flow diagram of the algorithm is shown in Figure 1 . To implement this procedure for a given model it is necessary to define bounds for input parameters and model outputs (e.g., steady states, or dynamic behavior). If bounds cannot be defined empirically, feasible ranges of parameter values can be asserted from physiological knowledge or theoretical considerations (e.g., the tissue concentration of a species may not be known, but typical weight and water content of that tissue may be known -putting an upper limit on the species concentration).
We have provided a detailed description of terminology, definitions, and the derivation of this algorithm in Table 1 and the supplementary material. Briefly, our approach is to generate a large number of 'plausible patients. ' We define these patients as a parameter set for which every component of the model (whether it be the parameter values themselves, computed species concentrations, or combinations of these that are experimentally measureable) falls into a biologically plausible range. From this 'plausible population' we can then select the virtual population such that it matches the empirical distribution of interest. This is achieved by calculating a probability of inclusion of a plausible patient into the virtual population. This probability is computed from both the empirical distribution and the density of plausible patients -see the supplementary materials for more details.
An important prerequisite to this approach is the ability to generate a large number of plausible patients within the region of the empirical data. To accelerate ! 6! this process we take an initial parameter guess (within the predefined bounds) and optimize this choice until the required outputs are within physiologically plausible ranges. Rather than optimize to specific points, it is more efficient to be agnostic as to where in the plausible ranges the optimization routine ends. To implement this we shift the typical cost function !(!) we would use optimizing a model to a new function, !(!), where we consider both as purely dependent on the parameter set !. If we constrain parameters using a number of model outputs
To generate plausible patients, we modify this sum-of-squared errors expression
where ! ! and ! ! are the predefined plausible upper and lower bounds, respectively, for ! ! ! . This expression ensures that if ! ! ! is in the plausible range then the contribution of the corresponding term in the expression is zero.
The effect of replacing !(!) with !(!) is visualized in 2-D in Figure 2 .
! !
To test this approach we used a previously published model of cholesterol metabolism 17 . We chose this model because we could use publically available data from the NHANES database 16 to establish the empirical multi-variate distribution for LDL cholesterol, HDL cholesterol and total cholesterol (LDL c , ! 7! HDL c and TC, respectively). Note that the distribution of these variables is well approximated by a multivariate log-normal distribution ( Supplementary Figure 1 ).
For the remainder of the paper we will describe these variables, either as model 
Results! !
We generated ~300,000 plausible patients using the algorithm. As expected, the initial plausible population does not match the population-level statistics of the NHANES data ( Figure 3 ) but covers the empirical distribution (i.e., where there are likely to be empirical observations there are plausible patients).
We proceeded by calculating the probability of inclusion for each 'plausible patient'. Once calculated, we established that most of the 'plausible patients' are highly unlikely to be in the final distribution ( Figure 4 ). This is due to the relative density of the plausible population to the empirical distribution. With these probabilities, only ~2% of the plausible population was selected to be in the When selecting a subset of VPs from a larger population, one concern is that the selected subset of VPs does not reflect the variability of the original ensemble, which was generated from the biologically plausible range of the parameters.
Analyzing the final fitted population, we found little change in either the distribution of parameters or the correlation structure between the parameters ( Figure 6 and Supplementary Figure 3 ). This also shows that despite the virtual population being constrained against the NHANES data the parameter values of the virtual population ( Figure 6B ) are only slightly better constrained than those of the plausible population. Furthermore, correlations between parameters are only slightly increased in the virtual population ( Figure 6D ) versus the plausible population ( Figure 6C ). At least in this case, constraining all outputs into realistic ranges is a more stringent constraint than selection of a virtual population. To efficiently generate plausible patients we firstly bound every parameter in the model into a plausible range. For some parameters, whose values are unknown, this range will be very wide. Other parameters may be known very accurately.
We use this range to generate an initial parameter guess by random sampling from a uniform distribution defined by the parameter range. Recall that, plausible patient ! ! is such that !(! ! ) ∈ !. Therefore, an initial parameter guess will likely not be a plausible patient. To find a plausible patient from an initial parameter guess we use an optimization routine seeded at the initial guess. This routine is required to converge to the space !, but we are agnostic as to where in !. In theory, we could prescribe a set of points in ! to converge to such that the plausible population matches the data distribution !. In practice, it is faster to apply the following procedure and check that the generated plausible population ! 15! has significant coverage of the empirical population. Consider a typical optimization problem for convergence to a set of data points ! ! , then the costfunction !(!) to be minimized is typically taken to be the sum of squared errors:
To find a plausible population we want to converge the solution to the region ! rather than a point. To do this we will construct a new cost-function !(!). Recall
If we take the cost-function to be
The advantage of this approach, and in particular this cost function, is the computational cost of minimization of this function is many orders of magnitude lower than minimization of the cost-function ! ! .! To find multiple distinct solutions of ! ! = 0, we use repeated simulated annealing (MATLAB) with different initial guesses. The optimization can be halted once a solution to ! ! = 0 was found. Each solution we identify is then a member of the plausible population ! !" .
Once we have generated ! !" we can evaluate how well it matches the empirical distribution, !. By definition (because all measurements are in physiological range) it is plausible that !(! !" ) could be a distributed approximately like !, that is !(! !" )~!, however for any relatively complex model it is highly unlikely this ! 16! will be the case without refinement. We therefore need to find a subset ! !"! ⊆ ! !" such that !(! !"! )~!, if this requirement is satisfactorily met then our subset ! !"! is a virtual population and each ! ! ∈ ! !"! is a virtual patient. To identify this subset we use a method closely related to the rejection-sampling algorithm, which is typically used to generate observations from a distribution where it would otherwise be difficult to do so. The distinction with the approach here is that we have a given prior distribution to select from (this is free to choose in the rejection-sampling algorithm, although does impact computation time), and we require an additional step that identifies the optimal size of the final virtual population. To illustrate this approach, consider the following.
For notation purposes, construct the selection function !:
Then, from Bayes' Theorem, 
A priori we do not know ! ! ! ! = 1 , which is the probability if we pick a plausible patient at random that they are in ! !"! . However we do know that it is a constant for a fixed plausible population Hence, we can write
where ! is a constant that we will fit by optimization of the virtual population -this controls the expected number of virtual patients in the virtual population. In the limit that the volume of the region !, centered around the point !, tends to zero.
So
where ! ! is the multivariate probability density function (pdf) for the observed data !, and ! !" (!) is an estimate of the density of the plausible population at !.
Given that we do not normalize this estimate such that ! is a pdf, the constant of proportionality is rescaled and renamed from ! to !. We call this ratio 'relative prevalence'. Intuitively, in regions where the empirical distribution is very dense selection is more likely. Conversely, where the plausible population is very dense relative to the empirical distribution selection is unlikely.
!
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Since the plausible population may be quite sparse in some regions, a robust density estimate is required. We found that finding the spherical volume around !, with radius defined by the distance to the 5 th nearest-neighbor, ! ! ! , led to such an estimate: ! !" ! = !5/! ! (!), which has units patients/unit volume because there are five plausible patients within the volume ! ! (!).
With this selection probability known for each plausible population, subsets matching the empirical distribution can be found by selection patients from ! !" with probability as calculated above. Note that repeating this selection process will lead to a distinct virtual population.
To fit the parameter ! we optimize the virtual population by comparison with the known empirical distribution. Goodness-of-fit is evaluated by the average (over all dimensions) univariate Kolmogorov-Smirnov test-statistic. To find the optimal value of ! a stochastic non-gradient based method is required, because for a repeated evaluation with fixed ! a different virtual population is selected, potentially with different goodness-of-fit to the data. To establish optimal values of !,!we again employed simulated annealing to accomplish this. Technically, for any !,
should place an upper bound on the value of !. However, practically we do not implement this bound and instead seek the best fit to the data (which may include plausible patients for whom this value is greater than one, which we interpret as 'always selected').
!
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The success of this method hinges on generating enough plausible patients in the model that reasonably cover the empirical distribution. Otherwise, even though you can still estimate the probability of inclusion into the virtual population (provided a reasonable density estimate is possible), the expected number of virtual patients in the population (!. ! ! ! ! = 1 , where ! is the number of plausible patients) is too low for a reasonable match to the data. Hence, failure of this algorithm is easily identified by either ! being too small to be useful, or by a large average Kolmogorov-Smirnov test-statistic being -we have found that values greater than 0.2 tend to lead to fits that are not acceptable visually. This statistic does not assess goodness-of-fit of the cross-correlation. We recommend either visual checks or calculation of the correlation matrix for the virtual population for comparison. is a virtual population that matches NHANES data, and is selected from the plausible population (blue histogram) based on displayed probability. Any quantity that is calculated from the model that can be experimentally measured i.e. X i (t), dX i (t)/dt, g(X)….
Figure Captions:
Plausible Patient
A parameter set defining the model Each parameter and physiological outcome is within biologically plausible ranges.
Plausible Population A collection of Plausible Patients
None-specifically (all inherited from plausible patients)
Virtual Population (VPop)
A subset of the plausible population Distribution matches the physiological outcomes for which we have such information.
Virtual Patient (VP)
A plausible patient that is also in the virtual population.
Parameters and physiological outcomes in plausible ranges. Probability of observing set of observations in VP approximates probability of observations in real patient. 
